Skip to main content
Clinical Trials/JPRN-UMIN000006199
JPRN-UMIN000006199
Completed
未知

A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder. - - A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder.

Advanced Clinical Research Organization0 sites12 target enrollmentSeptember 1, 2011
Conditionstype2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
type2 diabetes
Sponsor
Advanced Clinical Research Organization
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Advanced Clinical Research Organization

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients having been treated by sulfonylureas within 3 months. 2\) Patients treated by hyperlipidemia of fibrates. 3\) Patients with a BMI of 40 or more. 4\) Patients falling under the \[contraindication] in attached files of the experimental drugs. 5\) Patients falling under the \[Special caution needed] in attached files of the experimental drugs and whom have high disability, and whom principal investigator concludes to be unsuitable for the test. 6\) Patients whom principal investigator concludes to be unsuitable for the test, in other reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials